Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus

References

1. Aizaki H., Morikawa K., Fukasawa M., Hara H., Inoue Y., Tani H., Saito K., Nishijima M., Hanada K. et al. 2008; Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol 82:5715–5724 [View Article][PubMed]
   [Google Scholar]
2. Akazawa D., Date T., Morikawa K., Murayama A., Miyamoto M., Kaga M., Barth H., Baumert T. F., Dubuisson J., Wakita T. 2007; CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 81:5036–5045 [View Article][PubMed]
   [Google Scholar]
3. André P., Komurian-Pradel F., Deforges S., Perret M., Berland J. L., Sodoyer M., Pol S., Bréchot C., Paranhos-Baccalà G., Lotteau V. 2002; Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928 [View Article][PubMed]
   [Google Scholar]
4. Bartenschlager R., Penin F., Lohmann V., André P. 2011; Assembly of infectious hepatitis C virus particles. Trends Microbiol 19:95–103 [View Article][PubMed]
   [Google Scholar]
5. Bremer C. M., Bung C., Kott N., Hardt M., Glebe D. 2009; Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbiol 11:249–260 [View Article][PubMed]
   [Google Scholar]
6. Campbell S. M., Crowe S. M., Mak J. 2001; Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 22:217–227 [View Article][PubMed]
   [Google Scholar]
7. Campbell S. M., Crowe S. M., Mak J. 2002; Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16:2253–2261 [View Article][PubMed]
   [Google Scholar]
8. Campbell S., Gaus K., Bittman R., Jessup W., Crowe S., Mak J. 2004; The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol 78:10556–10565 [View Article][PubMed]
   [Google Scholar]
9. Chang K. S., Jiang J., Cai Z., Luo G. 2007; Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81:13783–13793 [View Article][PubMed]
   [Google Scholar]
10. Diaz O., Delers F., Maynard M., Demignot S., Zoulim F., Chambaz J., Trépo C., Lotteau V., André P. 2006; Preferential association of hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol 87:2983–2991 [View Article][PubMed]
    [Google Scholar]
11. Graham D. R., Chertova E., Hilburn J. M., Arthur L. O., Hildreth J. E. 2003; Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with β-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol 77:8237–8248 [View Article][PubMed]
    [Google Scholar]
12. Hambleton S., Steinberg S. P., Gershon M. D., Gershon A. A. 2007; Cholesterol dependence of varicella-zoster virion entry into target cells. J Virol 81:7548–7558 [View Article][PubMed]
    [Google Scholar]
13. Hishiki T., Shimizu Y., Tobita R., Sugiyama K., Ogawa K., Funami K., Ohsaki Y., Fujimoto T., Takaku H. et al. 2010; Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 84:12048–12057 [View Article][PubMed]
    [Google Scholar]
14. Huang H., Sun F., Owen D. M., Li W., Chen Y., Gale M. Jr, Ye J. 2007; Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104:5848–5853 [View Article][PubMed]
    [Google Scholar]
15. Icard V., Diaz O., Scholtes C., Perrin-Cocon L., Ramière C., Bartenschlager R., Penin F., Lotteau V., André P. 2009; Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One 4:e4233 [View Article][PubMed]
    [Google Scholar]
16. Jiang J., Luo G. 2009; Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol 83:12680–12691 [View Article][PubMed]
    [Google Scholar]
17. Lindenbach B. D., Meuleman P., Ploss A., Vanwolleghem T., Syder A. J., McKeating J. A., Lanford R. E., Feinstone S. M., Major M. E. et al. 2006; Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 103:3805–3809 [View Article][PubMed]
    [Google Scholar]
18. Megha, Bakht O., London E. 2006; Cholesterol precursors stabilize ordinary and ceramide-rich ordered lipid domains (lipid rafts) to different degrees. Implications for the Bloch hypothesis and sterol biosynthesis disorders. J Biol Chem 281:21903–21913 [View Article][PubMed]
    [Google Scholar]
19. Merz A., Long G., Hiet M. S., Brügger B., Chlanda P., Andre P., Wieland F., Krijnse-Locker J., Bartenschlager R. 2011; Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 286:3018–3032 [View Article][PubMed]
    [Google Scholar]
20. Nielsen S. U., Bassendine M. F., Burt A. D., Martin C., Pumeechockchai W., Toms G. L. 2006; Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80:2418–2428 [View Article][PubMed]
    [Google Scholar]
21. Owen D. M., Huang H., Ye J., Gale M. Jr 2009; Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 394:99–108 [View Article][PubMed]
    [Google Scholar]
22. Takeuchi T., Katsume A., Tanaka T., Abe A., Inoue K., Tsukiyama-Kohara K., Kawaguchi R., Tanaka S., Kohara M. 1999; Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116:636–642 [View Article][PubMed]
    [Google Scholar]
23. Thomssen R., Bonk S., Thiele A. 1993; Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol (Berl) 182:329–334 [View Article][PubMed]
    [Google Scholar]
24. Tulenko T. N., Boeze-Battaglia K., Mason R. P., Tint G. S., Steiner R. D., Connor W. E., Labelle E. F. 2006; A membrane defect in the pathogenesis of the Smith–Lemli–Opitz syndrome. J Lipid Res 47:134–143 [View Article][PubMed]
    [Google Scholar]
25. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H. G. et al. 2005; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796 [View Article][PubMed]
    [Google Scholar]
26. Wang J., Megha, London E. 2004; Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. Biochemistry 43:1010–1018 [View Article][PubMed]
    [Google Scholar]
27. Xu X., London E. 2000; The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39:843–849 [View Article][PubMed]
    [Google Scholar]
28. Xu X., Bittman R., Duportail G., Heissler D., Vilcheze C., London E. 2001; Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J Biol Chem 276:33540–33546 [View Article][PubMed]
    [Google Scholar]